Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation.
H Cuppens, … , B Nilius, J J Cassiman
H Cuppens, … , B Nilius, J J Cassiman
Published January 15, 1998
Citation Information: J Clin Invest. 1998;101(2):487-496. https://doi.org/10.1172/JCI639.
View: Text | PDF
Research Article Article has an altmetric score of 19

Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation.

  • Text
  • PDF
Abstract

In congenital bilateral absence of the vas deferens patients, the T5 allele at the polymorphic Tn locus in the CFTR (cystic fibrosis transmembrane conductance regulator) gene is a frequent disease mutation with incomplete penetrance. This T5 allele will result in a high proportion of CFTR transcripts that lack exon 9, whose translation products will not contribute to apical chloride channel activity. Besides the polymorphic Tn locus, more than 120 polymorphisms have been described in the CFTR gene. We hypothesized that the combination of particular alleles at several polymorphic loci might result in less functional or even insufficient CFTR protein. Analysis of three polymorphic loci with frequent alleles in the general population showed that, in addition to the known effect of the Tn locus, the quantity and quality of CFTR transcripts and/or proteins was affected by two other polymorphic loci: (TG)m and M470V. On a T7 background, the (TG)11 allele gave a 2.8-fold increase in the proportion of CFTR transcripts that lacked exon 9, and (TG)12 gave a sixfold increase, compared with the (TG)10 allele. T5 CFTR genes derived from patients were found to carry a high number of TG repeats, while T5 CFTR genes derived from healthy CF fathers harbored a low number of TG repeats. Moreover, it was found that M470 CFTR proteins matured more slowly, and that they had a 1.7-fold increased intrinsic chloride channel activity compared with V470 CFTR proteins, suggesting that the M470V locus might also play a role in the partial penetrance of T5 as a disease mutation. Such polyvariant mutant genes could explain why apparently normal CFTR genes cause disease. Moreover, they might be responsible for variation in the phenotypic expression of CFTR mutations, and be of relevance in other genetic diseases.

Authors

H Cuppens, W Lin, M Jaspers, B Costes, H Teng, A Vankeerberghen, M Jorissen, G Droogmans, I Reynaert, M Goossens, B Nilius, J J Cassiman

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 Total
Citations: 1 5 6 3 6 13 5 7 10 12 6 8 11 10 29 14 14 14 21 17 27 22 7 13 10 10 11 3 315
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2007 (21)

Title and authors Publication Year
Detection of cystic fibrosis transmembrane conductance regulator activity in early-phase clinical trials
SM Rowe, F Accurso, JP Clancy
Proceedings of the American Thoracic Society 2007
Is genetic analysis helpful for diagnosing chronic pancreatitis in its early stage?
S Naruse, K Fujiki, H Ishiguro
Journal of Gastroenterology 2007
A common variant in combination with a nonsense mutation in a member of the thioredoxin family causes primary ciliary dyskinesia
B Duriez, P Duquesnoy, E Escudier, AM Bridoux, D Escalier, I Rayet, E Marcos, AM Vojtek, JF Bercher, S Amselem
Proceedings of the National Academy of Sciences 2007
Comprehensive and rapid genotyping of mutations and haplotypes in congenital bilateral absence of the vas deferens and other cystic fibrosis transmembrane conductance regulator-related disorders
C Bareil, C Guittard, JP Altieri, C Templin, M Claustres, M Georges
The Journal of molecular diagnostics : JMD 2007
SR protein-mediated inhibition of CFTR exon 9 inclusion: molecular characterization of the intronic splicing silencer
E Buratti, C Stuani, GD Prato, FE Baralle
Nucleic Acids Research 2007
Validation of Cystic Fibrosis Mutation Analysis Using ABI 3130XL Genetic Analyzer
CK Huang, Q Pan
Diagnostic Molecular Pathology 2007
Molecular characterization of the cystic fibrosis transmembrane conductance regulator gene in congenital absence of the vas deferens
A Grangeia, R S??, F Carvalho, J Martin, E Girodon, J Silva, L Ferr??z, A Barros, M Sousa
Genetics in Medicine 2007
Cystic Fibrosis and Formes Frustes of CFTR-Related Disease
KW Southern
Respiration 2007
A variable poly-T sequence modulates α-synuclein isoform expression and is associated with aging
K Beyer, J Humbert, A Ferrer, JI Lao, P Latorre, D Lopez, E Tolosa, I Ferrer, A Ariza
Journal of Neuroscience Research 2007
Association of Pancreas Divisum and Recurrent Acute Pancreatitis With the IVS8-5T-12TG Allele of the CFTR Gene and CFTR Dysfunction
X Dray, I Fajac, T Bienvenu, A Chryssostalis, P Sogni, D Hubert
Pancreas 2007
Primary Sclerosing Cholangitis in Childhood is Associated with Abnormalities in Cystic Fibrosis–Mediated Chloride Channel Function
H Pall, J Zielenski, MM Jonas, DA DaSilva, KM Potvin, XW Yuan, Q Huang, SD Freedman
The Journal of Pediatrics 2007
Variable Penetrance And Expressivity of The Splice Altering 5T Sequence in The Cystic Fibrosis Gene
RV Lebo, WW Grody
Genetic Testing 2007
Atypical Patterns of Inheritance
AL Gropman, DR Adams
Seminars in Pediatric Neurology 2007
Spectrum of mutations and variants/haplotypes of CFTR and genotype-phenotype correlation in idiopathic chronic pancreatitis and controls in Chinese by complete analysis
MC Chang, YT Chang, SC Wei, YW Tien, PC Liang, IS Jan, YN Su, JM Wong
Clinical Genetics 2007
Contribution of the CFTR gene, the pancreatic secretory trypsin inhibitor gene (SPINK1) and the cationic trypsinogen gene (PRSS1) to the etiology of recurrent pancreatitis
M Tzetis, M Kaliakatsos, M Fotoulaki, A Papatheodorou, S Doudounakis, A Tsezou, P Makrythanasis, E Kanavakis, S Nousia-Arvanitakis
Clinical Genetics 2007
Does cystic fibrosis neonatal screening detect atypical CF forms? Extended genetic characterization and 4-year clinical follow-up
L Narzi, G Ferraguti, A Stamato, F Narzi, SB Valentini, A Lelli, I Delaroche, M Lucarelli, R Strom, S Quattrucci
Clinical Genetics 2007
TG15 T5 allele in clinically discordant monozygotic twins with cystic fibrosis
L Picci, M Cameran, M Scarpa, U Pradal, P Melotti, BM Assael, C Castellani
American Journal of Medical Genetics Part A 2007
N1303K and IVS8-5T, clinical presentation within a family with atypical cystic fibrosis
KV Hoorenbeeck, K Storm, J Ende, M Biervliet, KN Desager
Journal of Cystic Fibrosis 2007
Genetic screening for cystic fibrosis: An overview of the science and the economics
P Brice, J Jarrett, M Mugford
Journal of Cystic Fibrosis 2007
Evaluating candidate agents of selective pressure for cystic fibrosis
EM Poolman, AP Galvani
Journal of The Royal Society Interface 2007
Simple Method for Haplotyping the Poly(TG) Repeat in Individuals Carrying the IVS8 5T Allele in the CFTR Gene
V Mantovani, P Garagnani, P Selva, C Rossi, S Ferrari, M Cenci, N Calza, V Cerreta, D Luiselli, G Romeo
Clinical chemistry 2007

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 policy sources
Referenced in 1 patents
On 1 Facebook pages
Referenced in 3 clinical guideline sources
94 readers on Mendeley
See more details